Much like the rest of the United States, residents of the District of Columbia are struggling with substance use disorder (SUD) rate increases and high rates of opioid-related deaths. Unfortunately, these are multi-faceted issues that require year-long initiatives and systematic programs to address the myriad causes of addiction.
MSDC stands as a partner to the District government and private entities to help arrest the rates of opioid and substance abuse in the District. Through our advocacy for better prescribing practices, education on addiction, and even helping our own community through our Physician Health Program, MSDC is working to make DC a leader in reducing SUD, OUD, and addiction.
On a related note, MSDC is passionate about helping patients make prescriptions and medication more affordable. Whether expanding access to biosimilars or advocating for more affordable co-pays, MSDC wants to help our patients afford the medications they need.
MSDC Statement and Testimony on Opioid and Prescription Issues
MSDC Leaders Testify Before Board of Medicine and Council
July 30, 2020
Three MSDC leaders testified on numerous important health topics yesterday, furthering the Society's mission to make DC the best place to practice medicine,Continue Reading
MSDC President Testifies at Committee on Health Budget Hearing
June 10, 2020
MSDC President Dr. Pineda told the Council what steps needed to be taken to ensure a robust physician network across the District.Continue Reading
DC Health Releases 2019 Community Health Needs Assessment
February 20, 2020
The DC Health report is a snapshot of the District's overall health through various metrics.Continue Reading
Sample of Legislation MSDC is Tracking on Opioid and Prescription Policy
(See the whole list of bills here)
What does it do? The bill authorizes licensed pahrmacists to dispense interchangeable biological products and requires notifications to physicians when such interchangeables are dispensed.
MSDC position: MSDC has a position of priority support on this legislation, identifying its passage as one of its highest legislative priorities.
Current status: The bill is expected to be marked up by the Committee on Health on March 5
What does it do? The bill requires prescription opioid medications to include a statement that the drug is an opioid and opioids may cause dependence, addiction, or overdoes.
MSDC position: MSDC is considering a support position for the legislation.
Current status: The bill will have a hearing before the Committee on Health on June 18, 2020.
What does it do? The bill prohibits insurance companies from factoring the use of PreP in decisions related to disability, life, or long-term care policies.
MSDC position: MSDC supports this legislation
Current status: The bill was introduced on January 8, 2019 and assigned to the Committee on Business and Economic Development.